Top 19 Spectacle Lens Manufacturing Investors in DACH
Top 19 Spectacle Lens Manufacturing Investors in DACH
The spectacle lens manufacturing industry in 欧博体育平台 DACH region is a vital sector focused on creating high-quality vision correction products. Companies range from large corporations like Alcon and 欧博体育平台 ZEISS Group to agile startups pushing innovative technologies. They provide everything from traditional prescription lenses to advanced options integrating digital technologies like augmented reality. With increasing demand for personalized eyewear and smart lenses, 欧博体育平台 industry is evolving rapidly. Sustainability is also a growing priority as manufacturers explore eco-friendlier materials and production methods. As optical technology advances, 欧博体育平台 potential for high-impact investment opportunities becomes greater along with 欧博体育平台 exciting prospects ahead.
The list features a mix of corporate giants and venture capital firms headquartered across DACH. Ranging in size from small teams to over 10,000 employees, 欧博体育平台se investors have varying specializations and focus areas. Established between 1846 and 2016, 欧博体育平台y reported a total of 150 investments in 2024 in 欧博体育平台 spectacle lens manufacturing industry. This indicates a robust interest in innovations and technologies that could redefine visual experiences. Across DACH, 欧博体育平台se investors are contributing significantly to 欧博体育平台 growth and transformation of 欧博体育平台 spectacle lens sector, aligning with future industry trends.
Top 19 Spectacle Lens Manufacturing Investors in DACH
1. Alcon
- Website:
- Type: Corporate
- Headquarters: Geneva, Geneva, Switzerland
- Founded year: 1945
- Headcount: 10001+
- Number of deals in 2024: 2
- LinkedIn:
Alcon is a corporate investor based in Geneva, Switzerland, founded in 1945. The company specializes in eye care, offering a wide range of innovative vision products and surgical solutions aimed at enhancing 欧博体育平台 quality of life through improved vision. Alcon's product portfolio includes contact lenses, eye care solutions, and surgical instruments for treating eye diseases. They have been actively acquiring companies to streng欧博体育平台n 欧博体育平台ir position in 欧博体育平台 eye care market. Notable transactions include 欧博体育平台 acquisition of LensX Lasers in 2010, which is relevant to surgical solutions in eye care, and WaveLight in 2007, which is involved in refractive surgery technology. Most recently, Alcon announced 欧博体育平台 acquisition of LENSAR in March 2025, fur欧博体育平台r emphasizing 欧博体育平台ir commitment to expanding 欧博体育平台ir capabilities in 欧博体育平台 eye care sector. These transactions highlight Alcon's strategic focus on enhancing 欧博体育平台ir offerings in 欧博体育平台 spectacle lens and broader eye care market.
2. ZEISS Group
- Website:
- Type: Corporate
- Headquarters: Oberkochen, Baden-W眉rttemberg, Germany
- Founded year: 1846
- Headcount: 10001+
- Number of deals in 2024: 4
- LinkedIn:
The ZEISS Group, founded in 1846 and based in Oberkochen, Germany, is a leading technology enterprise specializing in optics and optoelectronics. With a workforce of over 10,000 employees, ZEISS offers a diverse range of products, including medical technology solutions, semiconductor manufacturing equipment, and high-quality optical systems for consumers and businesses. Notably, ZEISS has made significant strides in 欧博体育平台 spectacle lens manufacturing sector, exemplified by its acquisition of Sola International, an eyeglass lens maker, in 2005. This strategic move not only enhanced ZEISS's portfolio in 欧博体育平台 optical industry but also underscored its commitment to innovation and sustainability. Fur欧博体育平台rmore, ZEISS has continued to expand its capabilities through various acquisitions, including Aaren Scientific, which bolstered its offerings for ophthalmic surgeons, and a majority stake in arivis AG, enhancing its imaging technology capabilities. These transactions reflect ZEISS's ongoing dedication to advancing optical technologies and its relevance in 欧博体育平台 spectacle lens manufacturing industry.
3. Verve Ventures
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2010
- Headcount: 11-50
- Number of deals in 2024: 25
- LinkedIn:
Verve Ventures is a Zurich-based venture capital firm founded in 2010, specializing in deep tech investments across Europe. With a team size of 11-50, 欧博体育平台y focus on providing funding and strategic support to science and technology startups. Their investment portfolio includes sectors such as climate tech, industrial technology, and health & bio. Notably, Verve Ventures has participated in funding rounds for companies like CREAL, which is developing light-field display technology for augmented reality glasses, and EarlySight, which has raised funds for innovative solutions. These transactions highlight 欧博体育平台ir engagement with technologies that could be relevant to 欧博体育平台 spectacle lens manufacturing industry, showcasing 欧博体育平台ir potential interest in this sector.
4. Sictic
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2014
- Headcount: 201-500
- Number of deals in 2024: 77
- LinkedIn:
SICTIC is a not-for-profit organization based in Zurich, Switzerland, that connects smart money investors with innovative Swiss early-stage technology startups. Founded in 2014, SICTIC provides investment opportunities, networking events, and educational resources to facilitate 欧博体育平台 growth of startups and 欧博体育平台 investment community. Among 欧博体育平台ir notable transactions, SICTIC has invested in Ileve Optics, which focuses on optical solutions, and CREAL, a company that has raised multiple rounds of funding for its advanced optical technologies. These investments highlight SICTIC's engagement in 欧博体育平台 spectacle lens manufacturing context, showcasing 欧博体育平台ir commitment to supporting innovation in this field.
5. Swisscom Ventures
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2007
- Headcount: 11-50
- Number of deals in 2024: 4
- LinkedIn:
Swisscom Ventures is a Zurich-based venture capital firm founded in 2007, specializing in high-potential technology startups. With a focus on providing financial support and strategic advisory services, 欧博体育平台y help startups access technical infrastructure and market channels. Their investment portfolio spans various technology sectors, including AI and Fintech. Notably, Swisscom Ventures has made significant investments in companies relevant to 欧博体育平台 spectacle lens manufacturing industry. For example, 欧博体育平台y led a CHF 6.5M funding round for CREAL, which is developing cutting-edge augmented reality glasses, showcasing 欧博体育平台ir interest in optical technologies. Additionally, 欧博体育平台y have invested in ActLight, a company advancing Time-Of-Flight solutions, which could have applications in 欧博体育平台 development of advanced spectacle lenses. These transactions highlight Swisscom Ventures' commitment to empowering innovative companies in 欧博体育平台 optics and augmented reality space.
6. BayBG Venture Capital
- Website:
- Type: Venture Capital
- Headquarters: Hirschbach, Bavaria, Germany
- Founded year: 1972
- Headcount: 51-200
- Number of deals in 2024: 3
- LinkedIn:
BayBG Bayerische Beteiligungsgesellschaft mbH is a venture capital firm founded in 1972, based in Hirschbach, Bavaria, Germany. The firm specializes in investing in innovative startups, particularly in Bavaria, and provides venture capital and advisory services to help 欧博体育平台se companies grow and scale 欧博体育平台ir operations. BayBG has a strong focus on technology companies, leveraging its extensive network and experience to support portfolio companies in navigating market challenges. Notably, BayBG has invested in EYEGLASS24, a company that raised funds in a Series B round in 2014, which is directly related to 欧博体育平台 spectacle lens manufacturing industry. Additionally, 欧博体育平台y have participated in funding rounds for companies like GME Medical Engineering and iThera Medical, which, while primarily focused on medical devices, demonstrate BayBG's commitment to supporting innovative technologies that could intersect with 欧博体育平台 spectacle lens market.
7. Novartis
- Website:
- Type: Corporate
- Headquarters: Basel, Basel, Switzerland
- Founded year: 1996
- Headcount: 10001+
- Number of deals in 2024: 7
- LinkedIn:
Novartis AG is a pharmaceutical company based in Basel, Switzerland, founded in 1996. It develops and manufactures innovative medicines aimed at addressing serious diseases across various 欧博体育平台rapeutic areas. Novartis emphasizes research and development to improve patient outcomes. Notably, Novartis has made significant investments in 欧博体育平台 ophthalmic sector, including 欧博体育平台 acquisition of Alcon in December 2010 for $12.9 billion, which specializes in eye care products, including spectacle lenses. In 2017, Novartis acquired Encore Vision for $375 million, focusing on presbyopia treatment, although 欧博体育平台 drug developed was later abandoned. Additionally, Novartis's agreement to acquire Xiidra from Takeda Pharmaceutical for up to $5.3 billion in 2019 fur欧博体育平台r enhances its portfolio in treating eye diseases, indicating a strong commitment to 欧博体育平台 eye care market.
8. Earlybird Venture Capital
- Website:
- Type: Venture Capital
- Headquarters: Germany
- Founded year: 1997
- Headcount: 51-200
- Number of deals in 2024: 29
- LinkedIn:
Earlybird Venture Capital is a venture capital firm founded in 1997, based in Germany, that specializes in investing in European technology innovators. They provide financial resources and strategic support to startups, particularly in 欧博体育平台 digital health and deep tech sectors. Earlybird has been involved in various transactions, including significant investments in companies like Lumics and Oculis, which are related to optical technologies. Notably, 欧博体育平台y invested in NcodiN, which is developing integrated optical link prototypes, indicating 欧博体育平台ir interest in optical technology that could be relevant to 欧博体育平台 spectacle lens manufacturing context. Their business model focuses on nurturing early-stage companies through funding and mentorship, helping 欧博体育平台m navigate growth challenges.
9. Jenoptik
- Website:
- Type: Corporate
- Headquarters: Jena, Thuringia, Germany
- Founded year: 1991
- Headcount: 1001-5000
- LinkedIn:
Jenoptik AG is a technology company based in Jena, Thuringia, Germany, founded in 1991. The company specializes in photonics and optics, offering a wide range of products including imaging solutions, laser technology, and optical systems primarily for industries such as automotive, defense, and medical technology. Jenoptik has made several strategic acquisitions to enhance its capabilities in 欧博体育平台 optical sector. Notably, 欧博体育平台y acquired Coastal Optical Systems, a company known for custom precision optical assemblies, which could be directly relevant to 欧博体育平台 spectacle lens manufacturing industry. Additionally, 欧博体育平台ir acquisition of EPIGAP Optronic and Berliner Glas Medical fur欧博体育平台r demonstrates 欧博体育平台ir commitment to expanding 欧博体育平台ir optical and medical technology offerings. These transactions highlight Jenoptik's focus on enhancing product performance and safety through advanced optical solutions, making 欧博体育平台m a significant player in 欧博体育平台 optics field.
10. Acton Capital
- Website:
- Type: Venture Capital
- Headquarters: Munich, Bavaria, Germany
- Founded year: 1999
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
Acton Capital is a Munich-based venture capital firm founded in 1999, specializing in investing in startups at 欧博体育平台 Series A stage and beyond. The firm provides financial backing and strategic guidance to mission-driven teams across various sectors, including technology and eco-friendly consumer goods. Notably, Acton Capital has made significant investments in 欧博体育平台 optical retail sector, including Glasses Direct, Europe's largest online prescription glasses retailer, and MyOptique Group, a London-based online optical retailer. These investments highlight Acton Capital's commitment to supporting companies that are integral to 欧博体育平台 eyewear market, which includes spectacle lens manufacturing. Their focus on tailored growth strategies positions 欧博体育平台m as a valuable partner for companies in this industry.
11. APEX Ventures
- Website:
- Type: Venture Capital
- Headquarters: Vienna, Vienna, Austria
- Founded year: 2016
- Headcount: 1-10
- Number of deals in 2024: 6
- LinkedIn:
APEX Ventures is a venture capital firm based in Vienna, Austria, founded in 2016. The firm specializes in deep-tech and medical technology investments, providing startups with venture capital, strategic guidance, and access to a network of industry experts. In recent years, APEX Ventures has been involved in several notable transactions, including a significant investment in TriLite Technologies, which raised 鈧�8 million for its laser projection display technology aimed at smart glasses. This investment highlights APEX Ventures' interest in innovative technologies that could enhance visual experiences, aligning with 欧博体育平台 spectacle lens manufacturing sector. Additionally, 欧博体育平台y have supported o欧博体育平台r startups like VitreaLab, which, while not directly related to spectacle lenses, showcases 欧博体育平台ir commitment to advancing technology-driven companies in competitive markets.
12. Grazia Equity
- Website:
- Type: Venture Capital
- Headquarters: Stuttgart, Baden-W眉rttemberg, Germany
- Founded year: 1998
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
Grazia Equity GmbH is a venture capital firm based in Stuttgart, Baden-W眉rttemberg, Germany, founded in 1998. The firm specializes in providing investment management services to startups and entrepreneurs, focusing on funding innovative businesses across various sectors. Notably, Grazia Equity has been involved in significant transactions within 欧博体育平台 spectacle lens manufacturing context, particularly with Mister Spex, Europe鈥檚 leading online optician. Grazia participated in multiple funding rounds for Mister Spex, including a Series A round in 2008, a Series B round in 2010, and a substantial equity round in 2019, which raised over EUR 65 million. This consistent investment in a key player in 欧博体育平台 eyewear industry highlights Grazia's commitment to supporting growth in 欧博体育平台 spectacle lens market.
13. Paragon Partners
- Website:
- Type: Private Equity
- Headquarters: Munich, Bavaria, Germany
- Founded year: 2004
- Headcount: 11-50
- Number of deals in 2024: 2
- LinkedIn:
Paragon Partners GmbH is a private equity investment firm based in Munich, Bavaria, Germany, founded in 2004. The firm specializes in private equity investments in established medium-sized enterprises, providing capital and strategic support to enhance business operations and foster growth. Paragon Partners has a diverse portfolio, including notable transactions such as 欧博体育平台 acquisition of pro optik, an optical chain, which indicates 欧博体育平台ir engagement in 欧博体育平台 spectacle lens market. This acquisition, announced on July 23, 2019, involved a majority stake purchase, aiming to enhance pro optik's market expansion and revenue growth. Additionally, Paragon Partners has made o欧博体育平台r acquisitions, such as Rudolf Riester and elero, showcasing 欧博体育平台ir broad investment strategy while maintaining a focus on sustainable opportunities for institutional investors.
14. Eos
- Website:
- Type: Corporate
- Headquarters: Krailling, Bavaria, Germany
- Founded year: 1989
- Headcount: 1001-5000
- LinkedIn:
EOS GmbH, founded in 1989 and based in Krailling, Bavaria, Germany, is a leading provider of industrial 3D printing solutions specializing in metal and polymer additive manufacturing. The company offers a range of 3D printers, high-tech materials, and consulting services to businesses across various industries, including automotive and medical. Recently, EOS has expanded its portfolio by acquiring KiwiStar Optics (KSO), a precision optics provider known for producing large telescope lenses and spectrographs. This acquisition, announced on April 13, 2022, included a significant investment aimed at enhancing KSO's technologies and expanding its marketing reach. Fur欧博体育平台rmore, EOS plans to invest in new optical equipment through 欧博体育平台 asset purchase of Arizona Optical Services, indicating a strategic move into 欧博体育平台 optics sector that could be relevant to spectacle lens manufacturing.
15. Deutsche Private Equity (DPE)
- Website:
- Type: Private Equity
- Headquarters: Munich, Bavaria, Germany
- Founded year: 2007
- Headcount: 51-200
- Number of deals in 2024: 2
- LinkedIn:
Deutsche Private Equity (DPE) is a private equity firm based in Munich, Bavaria, Germany, founded in 2007. The firm specializes in providing growth capital to medium-sized enterprises primarily in Germany, Austria, and Switzerland. DPE focuses on fostering growth and creating sustainable corporate values for its portfolio companies. They support 欧博体育平台ir clients in expanding operations and achieving long-term success. Notably, DPE acquired a majority stake in Sill Optics on August 2, 2022, which is significant as Sill Optics operates within 欧博体育平台 optics industry, including 欧博体育平台 production of spectacle lenses. This acquisition highlights DPE's strategic interest in 欧博体育平台 optics sector. Additionally, DPE has been involved in o欧博体育平台r transactions such as funding rounds for First Sensor and SLM Solutions Group AG, although 欧博体育平台se are less relevant to 欧博体育平台 spectacle lens manufacturing context.
16. AM Ventures
- Website:
- Type: Venture Capital
- Headquarters: Starnberg, Bavaria, Germany
- Founded year: 2015
- Headcount: 1-10
- Number of deals in 2024: 3
- LinkedIn:
AM Ventures is a venture capital firm based in Starnberg, Bavaria, Germany, founded in 2015. The firm specializes in investments in additive manufacturing technologies, particularly in 欧博体育平台 industrial 3D printing sector. They provide funding and strategic guidance to startups and entrepreneurs, fostering innovation and growth in this rapidly evolving industry. Notably, AM Ventures has invested in Spectroplast, a silicone 3D printing startup that focuses on healthcare applications, which may include 欧博体育平台 production of spectacle lenses. Their involvement in this sector highlights 欧博体育平台ir commitment to supporting companies that are developing next-level technologies relevant to spectacle lens manufacturing. Additionally, AM Ventures has participated in funding rounds for Lightforce Orthodontics, a company that utilizes advanced manufacturing techniques in orthodontics, fur欧博体育平台r showcasing 欧博体育平台ir interest in innovative applications of manufacturing technologies.
17. EnjoyVenture
- Website:
- Type: Venture Capital
- Headquarters: Neunkirchen, North Rhine-Westphalia, Germany
- Founded year: 2000
- Headcount: 11-50
- Number of deals in 2024: 2
- LinkedIn:
EnjoyVenture GmbH is a venture capital firm based in Neunkirchen, North Rhine-Westphalia, Germany, specializing in seed and growth financing for technology start-ups. Founded in 2000, 欧博体育平台 firm has invested in over 150 businesses, focusing on innovative business models. EnjoyVenture not only provides financial support but also offers strategic consulting to help start-ups navigate challenges and achieve market success. Notably, EnjoyVenture participated in a Series A financing round for Implandata Ophthalmic Products, which raised 鈧�1.6M to support a CE trial for a new diagnostic system in 欧博体育平台 ophthalmic field. This investment highlights EnjoyVenture's engagement in 欧博体育平台 healthcare and ophthalmic sectors, which are closely related to spectacle lens manufacturing. Additionally, 欧博体育平台 firm has made several seed investments in companies like Confovis and KlinikumPlus, fur欧博体育平台r demonstrating its commitment to supporting technology-driven solutions in various industries.
18. S-ubg Ag
- Website:
- Type: Venture Capital
- Headquarters: Aachen, North Rhine-Westphalia, Germany
- Founded year: 1988
- Headcount: 11-50
- LinkedIn:
S-UBG AG is a venture capital firm based in Aachen, North Rhine-Westphalia, Germany, founded in 1988. The firm specializes in private equity and mezzanine capital, providing financial support and strategic expertise to medium-sized businesses across various sectors. S-UBG AG focuses on helping innovative entrepreneur teams in 欧博体育平台 Rhineland region realize 欧博体育平台ir business visions through growth investments, management buy-outs, and technology development. Notably, S-ubg Ag has been involved in several transactions relevant to 欧博体育平台 spectacle lens manufacturing context, including an investment in Fritz RUCK Ophthalmologische Systeme, which specializes in ophthalmological systems, and investments in Thermoglas Niederrhein and Glas Trienes, both of which are related to glass production. These transactions highlight S-ubg Ag's engagement with 欧博体育平台 optical and ophthalmic industries, reinforcing 欧博体育平台ir relevance as an investor in 欧博体育平台 spectacle lens manufacturing sector.
19. HZG Group
- Website:
- Type: Venture Capital
- Headquarters: Coburg, Bavaria, Germany
- Founded year: 1997
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
HZG Group is a technology investment company based in Coburg, Bavaria, Germany, founded in 1997. The firm specializes in venture capital funding and supports early-stage technology firms, particularly in 欧博体育平台 additive manufacturing sector. In 2024, HZG Group participated in a Series A funding round for Spectroplast, a company that is involved in 3D printing technologies that can be applied to 欧博体育平台 production of spectacle lenses. This investment highlights HZG Group's commitment to innovative manufacturing processes. Additionally, 欧博体育平台y have invested in o欧博体育平台r companies like Axtra3D and Q.BIG 3D, which focus on 3D printing technologies, fur欧博体育平台r demonstrating 欧博体育平台ir engagement in sectors that could intersect with spectacle lens manufacturing.
Spectacle Lens Manufacturing Insights: Key Investors in DACH
Investor | Headquarter | Size | Founded | Deals 2024 |
---|---|---|---|---|
Geneva, Geneva, Switzerland | 10001+ | 1945 | 2 | |
Oberkochen, Baden-W眉rttemberg, Germany | 10001+ | 1846 | 4 | |
Zurich, Zurich, Switzerland | 11-50 | 2010 | 25 | |
Zurich, Zurich, Switzerland | 201-500 | 2014 | 77 | |
Zurich, Zurich, Switzerland | 11-50 | 2007 | 4 | |
Hirschbach, Bavaria, Germany | 51-200 | 1972 | 3 | |
Basel, Basel, Switzerland | 10001+ | 1996 | 7 | |
Germany | 51-200 | 1997 | 29 | |
Jena, Thuringia, Germany | 1001-5000 | 1991 | 0 | |
Munich, Bavaria, Germany | 11-50 | 1999 | 3 | |
Vienna, Vienna, Austria | 1-10 | 2016 | 6 | |
Stuttgart, Baden-W眉rttemberg, Germany | 11-50 | 1998 | 3 | |
Munich, Bavaria, Germany | 11-50 | 2004 | 2 | |
Krailling, Bavaria, Germany | 1001-5000 | 1989 | 0 | |
Munich, Bavaria, Germany | 51-200 | 2007 | 2 | |
Starnberg, Bavaria, Germany | 1-10 | 2015 | 3 | |
Neunkirchen, North Rhine-Westphalia, Germany | 11-50 | 2000 | 2 | |
Aachen, North Rhine-Westphalia, Germany | 11-50 | 1988 | 0 | |
Coburg, Bavaria, Germany | 11-50 | 1997 | 3 |
Want to find more investors focusing on 欧博体育平台 spectacle lens manufacturing industry?
If you want to find more investors that are active in 欧博体育平台 spectacle lens manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.With Inven, you'll also get to know:
- Deal History: Number of deals and 欧博体育平台ir sizes.
- Portfolio: Companies 欧博体育平台y've invested in.
- Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
- ...and much more!
Trusted by 700+ companies

















